Epilepsy Intractable Clinical Trial
— MEMREINSOfficial title:
Memory Retrieval and Encoding Investigated by Neural Stimulation
Verified date | April 2024 |
Source | University of Pennsylvania |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this research is to understand biomarkers of human memory through correlational analyses and to use focal electrical stimulation as a causal manipulation to understand how biomarkers of memory relate to other brain states and behavioral measures.
Status | Enrolling by invitation |
Enrollment | 800 |
Est. completion date | June 30, 2024 |
Est. primary completion date | June 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Expected to undergo intracranial implantation and postoperative electroencephalographic monitoring as part of a standard clinical procedure for the treatment of pharmacologically resistant epilepsy 2. Age 18 or older Exclusion Criteria: 1. Any physical or cognitive disability or illness that would limit their ability to perform cognitive tasks 2. Any medical condition that would, in the investigator's opinion, limit the subject's participation in the study. 3. Unable or unwilling to provide informed consent 4. MRI contraindications Standard clinical care includes a pregnancy test for female patients prior to the surgical implantation of the electrodes. Pregnant women are not surgically implanted. |
Country | Name | City | State |
---|---|---|---|
United States | Emory University Hospital | Atlanta | Georgia |
United States | University of Colorado, Denver | Aurora | Colorado |
United States | National Institute of Neurological Disorders and Stroke | Bethesda | Maryland |
United States | Beth Israel Deaconess Medical Center | Boston | Massachusetts |
United States | UT Southwestern Medical Center | Dallas | Texas |
United States | Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire |
United States | Columbia University | New York | New York |
United States | Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania |
United States | Thomas Jefferson University Hospital | Philadelphia | Pennsylvania |
United States | Mayo Clinic | Rochester | Minnesota |
United States | University of Texas Health Science Center at San Antonio | San Antonio | Texas |
Lead Sponsor | Collaborator |
---|---|
University of Pennsylvania | Columbia University, National Institute of Neurological Disorders and Stroke (NINDS) |
United States,
Ezzyat Y, Kragel JE, Solomon EA, Lega BC, Aronson JP, Jobst BC, Gross RE, Sperling MR, Worrell GA, Sheth SA, Wanda PA, Rizzuto DS, Kahana MJ. Functional and anatomical connectivity predict brain stimulation's mnemonic effects. bioRxiv [Preprint]. 2023 Aug 11:2023.07.27.550851. doi: 10.1101/2023.07.27.550851. — View Citation
Ezzyat Y, Wanda PA, Levy DF, Kadel A, Aka A, Pedisich I, Sperling MR, Sharan AD, Lega BC, Burks A, Gross RE, Inman CS, Jobst BC, Gorenstein MA, Davis KA, Worrell GA, Kucewicz MT, Stein JM, Gorniak R, Das SR, Rizzuto DS, Kahana MJ. Closed-loop stimulation of temporal cortex rescues functional networks and improves memory. Nat Commun. 2018 Feb 6;9(1):365. doi: 10.1038/s41467-017-02753-0. — View Citation
Kragel JE, Ezzyat Y, Lega BC, Sperling MR, Worrell GA, Gross RE, Jobst BC, Sheth SA, Zaghloul KA, Stein JM, Kahana MJ. Distinct cortical systems reinstate the content and context of episodic memories. Nat Commun. 2021 Jul 21;12(1):4444. doi: 10.1038/s41467-021-24393-1. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To use direct electrical stimulation to disentangle causal versus correlative biomarkers of verbal and spatial episodic memory | 1. We will use linear mixed effects models and L2-penalized logistic regression classifiers to compare periods of successful and unsuccessful performance in our tasks | Up to 4 weeks (typical duration of hospital stay) | |
Primary | To develop and test models of human brain dynamics in the presence of electrical stimulation | 2. We will compare spectral indices of brain activity before and after stimulation as a function of stimulation parameters. | Up to 4 weeks (typical duration of hospital stay) | |
Primary | To assess how reactivation of prior memories shapes subsequent recall and memory organization, including memory for the content, context and value of experiences. | 3. We will mathematical models of neural similarity described in detail in Halpern (2024) and Manning (2011, 2012) to test the reactivation mechanisms described in Lohnas et al. (2014) and Healey and Kahana (2015). | Up to 4 weeks (typical duration of hospital stay) | |
Primary | To determine whether state-dependent stimulation can separately be used to modulate encoding and retrieval processes | 4. We will evaluate the closed-loop stimulation protocol described in Kahana et al. (2023) in both encoding and retrieval. | Up to 4 weeks (typical duration of hospital stay) | |
Primary | To determine whether stimulation is more effective at modulating memory when targeted to regions with specific connectivity profiles to the medial temporal lobe | 5. We will compare recall rates during a free recall experiment with brain stimulation at sites with high network-mediated activation, as described in Solomon et al. (2018), versus low network-mediated activation. | Up to 4 weeks (typical duration of hospital stay) | |
Primary | To determine how simultaneous stimulation at multiple target sites can be optimized to modulate memory | 6. We will compare recall rates during a free recall experiment with no brain stimulation, stimulation at one site, and stimulation at multiple sites. | Up to 4 weeks (typical duration of hospital stay) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03014752 -
Comparison of the Effectiveness of the Outpatient Classical Ketogenic Diet and Modified Atkins Diet on Seizures Frequency, Nutritional Status and Some Biochemical Factors in Children and Adolescents With Intractable Epilepsy
|
Phase 2/Phase 3 | |
Terminated |
NCT03790436 -
Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet
|
N/A | |
Completed |
NCT05503511 -
Safety and Pharmacokinetic Study of NPT 2042 Soft-gelatin Capsules Administered Orally to Healthy Adult Subjects
|
Phase 1 | |
Completed |
NCT04763070 -
Ciprofloxacin in Drug-resistant Epilepsy
|
N/A | |
Completed |
NCT03403907 -
The Effect of Probiotic Supplementation in Drug-resistant Epilepsy Patients
|
N/A | |
Recruiting |
NCT04158531 -
REC2Stim as a Treatment for Refractory Epilepsy in the Primary Sensorimotor Cortex.
|
N/A | |
Recruiting |
NCT03289572 -
Microgrid II - Electrocorticography Signals for Human Hand Prosthetics
|
||
Enrolling by invitation |
NCT05332990 -
Multicenter Comparison of Interictal HFO as a Predictor of Seizure Freedom
|
||
Recruiting |
NCT04325360 -
Effects of Transcranial Direct Current Stimulation (tDCS) for the Treatment of Refractory Epilepsy
|
N/A | |
Active, not recruiting |
NCT05727943 -
Add-on Clioquinol in Drug-resistant Childhood Epilepsy: an Exploratory Study
|
Phase 2 | |
Recruiting |
NCT04649008 -
Localizing Epileptic Networks Using MRI and iEEG
|
Early Phase 1 | |
Active, not recruiting |
NCT03916848 -
Novel Network Analysis of Intracranial Stereoelectroencephalography
|
N/A | |
Completed |
NCT03646240 -
ABI-009 (Nab-rapamycin) for Surgically-Refractory Epilepsy (RaSuRE)
|
Phase 1 | |
Recruiting |
NCT03857074 -
Effects of Green Light Exposure on Epileptic Spikes in Patients With Refractory Epilepsy
|
N/A | |
Enrolling by invitation |
NCT03702127 -
TMS - Intracranial Electrodes
|
N/A | |
Recruiting |
NCT05015868 -
Contribution of Genetics, Non-invasive Methods and Neuropsychology in Focal Cryptogenic Epilepsies
|
N/A | |
Enrolling by invitation |
NCT06138808 -
5-SENSE Score Validation Study
|
||
Not yet recruiting |
NCT03741192 -
Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patient's Refractory to AEDs
|
N/A | |
Enrolling by invitation |
NCT05248269 -
Thermocoagulation in Drug Resistant Focal Epilepsy
|
N/A | |
Completed |
NCT04399954 -
Evaluation of Ketoflo
|
N/A |